You have 9 free searches left this month | for more free features.

Leucovorin Calcium (Folinic Acid)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)

Active, not recruiting
  • Autism Spectrum Disorder
  • Language Disorders
  • Levoleucovorin Calcium
  • Placebo
  • Phoenix, Arizona
  • +1 more
Oct 7, 2022

Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)

Active, not recruiting
  • Autism Spectrum Disorder
  • Language Disorders
  • Levoleucovorin Calcium
  • Placebo
  • Phoenix, Arizona
  • +1 more
Sep 26, 2022

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +5 more
  • Biospecimen Collection
  • +9 more
  • Scottsdale, Arizona
  • +2 more
Oct 11, 2023

Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Esophageal Cancer
  • (no location specified)
Jul 6, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Rectal Adenocarcinoma Trial in Chapel Hill (other, radiation, drug)

Withdrawn
  • Rectal Adenocarcinoma
  • Chemoradiation
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 2, 2021

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)

Recruiting
  • Pancreatic Cancer
  • Sydney, New South Wales, Australia
  • +2 more
Oct 19, 2023

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)

Recruiting
  • Pancreas Cancer
  • Adenocarcinoma of the Pancreas
  • Omaha, Nebraska
    University of Nebraska Medical Center
Mar 31, 2022

Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester

Not yet recruiting
  • Clinical Stage IV Gastric Cancer AJCC v8
  • +4 more
  • Aldesleukin
  • +10 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 5, 2023

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction

Not yet recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +9 more
  • Atezolizumab
  • +12 more
  • (no location specified)
Apr 26, 2023

Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

Recruiting
  • Borderline Resectable Pancreatic Carcinoma
  • +8 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 25, 2022

Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)

Active, not recruiting
  • Pancreatic Cancer
  • CPI 613
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Fluorouracil, Gemcitabine,

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Boise, Idaho
  • +42 more
Jun 8, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7 Trial in Phoenix,

Active, not recruiting
  • Gastric Cardia Adenocarcinoma
  • +7 more
  • Phoenix, Arizona
  • +1 more
May 12, 2022

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Columbus

Recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 14, 2021

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +6 more
  • Balstilimab
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Nov 17, 2022

Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +42 more
  • Duarte, California
  • +9 more
Jan 21, 2023

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022